Hikal has signed a multi-year contract with a Europe-based global agrochemical company to supply a specialised agrochemical product to markets worldwide. The contract, signed by Hikal’s Crop Protection division, covers contract development and manufacturing (CDMO) of the product for which Hikal undertook process development and scale-up. Commercial launch is expected towards the end of FY 2026-27, with volumes anticipated to grow progressively as regulatory approvals are secured across global markets.
The partnership underscores Hikal’s capabilities in process development and commercialisation, demonstrating its ability to translate customer requirements into long-term manufacturing opportunities. It also strengthens Hikal’s Crop Protection business by expanding its portfolio of specialised offerings for global customers. Hikal partners with global companies across pharmaceuticals, crop protection, animal health and specialty chemicals, leveraging its research and development, process chemistry and manufacturing capabilities to support customers from development through commercial production.
Hikal offers solutions across the life sciences value chain. The company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities.
